State, Contacted, Interested, Registered,Pre-Screened, Qualified, Enrolled
STRENGTH - Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia ,18656,16243,12984,10143,8890,6500
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer,15302,10000,8344,5343,3938,2349
MiStent   Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStentå System),12000,8495,7348,4543,2341,1234